Figure 1
From: A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Kaplan Meier overall survival and response to platinum treatment.
Figure 1 | Journal of Ovarian Research
From: A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
Kaplan Meier overall survival and response to platinum treatment.